US EditionPublished • loading... • Updated
Yuli Pharmaceuticals Acquires Bayer's Zam-Buk® and Vapex® Brands to Strengthen Its Health Consumer Products Portfolio.
Summary
5 Articles
5 Articles
The Daily News+2 Reposted by 2 other sources
Zuellig Pharma Strengthens Consumer Healthcare Portfolio with the Acquisition of Zam-Buk® and Vapex® Brands from Bayer
SINGAPORE - Media OutReach Newswire - 9 February 2026 - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has acquired all rights, title, and interest in and to the Zam-Buk® and Vapex® consumer healthcare brands…
Zuellig Pharma Strengthens Consumer Healthcare Portfolio with the
SINGAPORE – Media OutReach Newswire – 9 February 2026 – Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has acquired all rights, title, and interest in and to the Zam-Buk® and Vapex® consumer healthcare brands from Bayer Consumer Care AG for Thailand, Singapore, Indonesia, Malaysia and Brunei. Zam-Buk® is an […]
Coverage Details
Total News Sources5
Leaning Left1Leaning Right1Center1Last UpdatedBias Distribution34% Left, 33% Center, 33% Right
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
34% Left
L 34%
C 33%
R 33%
Factuality
To view factuality data please Upgrade to Premium
